Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Innovative Medicine

      Innovative Medicine

      Innovative Medicine
      August 7, 2013

      STELARA® Receives CHMP Positive Opinion For Treatment Of Psoriatic Arthritis

      STELARA Recommended for Approval in Adult Patients with Active Psoriatic Arthritis
      Learn more
      Innovative Medicine
      August 6, 2013

      New Data Confirms Circulating Tumor Cells Are Useful Predictors of Progression-free and Overall Survival

      First Study to Demonstrate Value of Circulating Tumor Cell Enumeration in Chinese Metastatic Breast Cancer Patients Published in Annals of Oncology
      Learn more
      Innovative Medicine
      July 18, 2013

      SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for TREATMENT OF MODERATELY TO SEVERELY ACTIVE Rheumatoid arthritis

      First Anti-TNF Infusion Therapy Approved in More Than a Decade for Patients Living with Moderately to Severely Active Rheumatoid Arthritis
      Learn more
      Innovative Medicine
      July 16, 2013

      Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students

      Learn more
      Innovative Medicine
      July 10, 2013

      New Drug Application Submitted to U.S. FDA for Ibrutinib in the Treatment of Two B-Cell Malignancies

      If approved, ibrutinib will address a high unmet need in relapsed/refractory chronic lymphocytic leukemia and relapsed/refractory mantle cell lymphoma
      Learn more
      Corporate
      July 2, 2013

      Mentor Announces Collaboration Agreement With Valeant Pharmaceuticals

      New physician loyalty program offers broad portfolio of aesthetic products
      Learn more
      Innovative Medicine
      June 28, 2013

      CHMP Gives A Positive Opinion For The Use Of VELCADE® As Retreatment And For Frontline Induction Therapy Before Stem Cell Transplantation

      Label updates could lead to significantly improved outcomes for patients with multiple myeloma
      Learn more
      Innovative Medicine
      June 28, 2013

      FDA Issues Complete Response Letter for XARELTO® (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome

      Learn more
      Innovative Medicine
      June 24, 2013

      Studies Reinforce INVOKANA™ (canagliflozin) (300mg) Provides Greater Improvements in Blood Glucose than Sitagliptin (100 mg) or Glimepiride (6 or 8 mg) in Adults with Type 2 Diabetes

      Phase 3 Results for INVOKANA™ Demonstrate Novel Type 2 Diabetes Medicine Also Provided Greater Secondary Endpoint Reductions in Weight and Systolic Blood Pressure
      Learn more
      Load more